SEBM Announces Speaker Lineup for 2024 EBMC in Orlando
The Society for Experimental Biology and Medicine (SEBM) is proud to announce its speaker lineup for the upcoming Experimental Biology and Medicine Conference (EBMC) at...
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the...
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Focus on Regenerative Medicine Combined with Best-in-Class Aesthetics Device Offering Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated...
Seraxis’ Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes
GMP-compliant manufacturing puts SR-02 on track to be industry’s second clinical-stage stem cell derived pancreatic islet transplant program. The third-party auditor’s FDA six-system approach yielded...
Royal Biologics Announces Commerical Launch of Derm-Maxx™ and Newly Formed Wound Care Division
Royal Biologics, Inc., a company specializing in Advanced Cellular & Autologous Technologies for Enhanced Surgical Solutions, today announced the commercial launch of Derm-Maxx™, an acellular...
Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson’s Disease Patients Worldwide in Japan
Biostar Stem Cell Research Institute has received approval from Japan's Ministry of Health, Labor and Welfare to Treat Parkinson's Disease. The combination of intravenous and...
Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA
Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and...
Isto Biologics Elevates Biologic Innovations Through Merger With Advanced Biologics/Biologica Technologies
Isto Biologics, a global leader in regenerative and autologous therapies, announced today their successful merger with Advanced Biologics (known commercially as Biologica Technologies), a California-based...
Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD
Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well...
Ark-La-Tex Health Center Introduces Revolutionary Regenerative Medicine Services in Texarkana
Ark-la-tex Health Center, a leading healthcare facility in Texarkana, is proud to announce the launch of its groundbreaking "Regenerative Medicine" services. Spearheaded by Dr. James...